12/11
09:00 am
psnl
New Publication Demonstrates the Importance of NeXT Personal Ultrasensitive Detection of Residual Disease in Lung Cancer
Low
Report
New Publication Demonstrates the Importance of NeXT Personal Ultrasensitive Detection of Residual Disease in Lung Cancer
12/11
07:14 am
psnl
Why Analysts See Personalis Story Shifting With Medicare Tailwinds And Biopharma Headwinds [Yahoo! Finance]
Low
Report
Why Analysts See Personalis Story Shifting With Medicare Tailwinds And Biopharma Headwinds [Yahoo! Finance]
12/1
07:02 pm
psnl
Personalis (NASDAQ:PSNL) was given a new $11.00 price target on by analysts at Morgan Stanley.
Low
Report
Personalis (NASDAQ:PSNL) was given a new $11.00 price target on by analysts at Morgan Stanley.
11/27
10:37 pm
psnl
Personalis: A Growth Inflection Is Imminent, Hold [Seeking Alpha]
Low
Report
Personalis: A Growth Inflection Is Imminent, Hold [Seeking Alpha]
11/18
04:01 pm
psnl
Personalis to Participate in the Piper Sandler 37th Annual Healthcare Conference
Medium
Report
Personalis to Participate in the Piper Sandler 37th Annual Healthcare Conference
11/11
12:21 pm
psnl
Personalis (NASDAQ:PSNL) had its price target raised by analysts at Morgan Stanley from $5.00 to $9.00. They now have an "equal weight" rating on the stock.
Low
Report
Personalis (NASDAQ:PSNL) had its price target raised by analysts at Morgan Stanley from $5.00 to $9.00. They now have an "equal weight" rating on the stock.
11/11
09:06 am
psnl
Personalis (NASDAQ:PSNL) had its price target raised by analysts at Guggenheim from $6.00 to $12.00. They now have a "buy" rating on the stock.
Medium
Report
Personalis (NASDAQ:PSNL) had its price target raised by analysts at Guggenheim from $6.00 to $12.00. They now have a "buy" rating on the stock.
11/11
08:09 am
psnl
Personalis (NASDAQ:PSNL) had its price target raised by analysts at BTIG Research from $11.00 to $12.00. They now have a "buy" rating on the stock.
Low
Report
Personalis (NASDAQ:PSNL) had its price target raised by analysts at BTIG Research from $11.00 to $12.00. They now have a "buy" rating on the stock.
11/10
09:20 am
psnl
Personalis Announces Medicare Coverage for Ultrasensitive MRD Test in Breast Cancer [Yahoo! Finance]
High
Report
Personalis Announces Medicare Coverage for Ultrasensitive MRD Test in Breast Cancer [Yahoo! Finance]
11/10
09:00 am
psnl
Personalis Announces Medicare Coverage for Ultrasensitive MRD Test in Breast Cancer
High
Report
Personalis Announces Medicare Coverage for Ultrasensitive MRD Test in Breast Cancer
11/9
12:43 am
psnl
How the Story Behind Personalis Is Evolving After New Earnings and Guidance Updates [Yahoo! Finance]
High
Report
How the Story Behind Personalis Is Evolving After New Earnings and Guidance Updates [Yahoo! Finance]
11/6
08:10 am
psnl
Personalis (NASDAQ:PSNL) had its price target raised by analysts at HC Wainwright from $8.50 to $10.00. They now have a "buy" rating on the stock.
Medium
Report
Personalis (NASDAQ:PSNL) had its price target raised by analysts at HC Wainwright from $8.50 to $10.00. They now have a "buy" rating on the stock.
11/5
10:03 am
psnl
Personalis (NASDAQ:PSNL) had its "buy" rating reaffirmed by analysts at Lake Street Capital.
Low
Report
Personalis (NASDAQ:PSNL) had its "buy" rating reaffirmed by analysts at Lake Street Capital.
11/5
07:19 am
psnl
Personalis (NASDAQ:PSNL) had its "buy" rating reaffirmed by analysts at Needham & Company LLC.
Medium
Report
Personalis (NASDAQ:PSNL) had its "buy" rating reaffirmed by analysts at Needham & Company LLC.
11/4
04:01 pm
psnl
Personalis Reports Third Quarter 2025 Financial Results
Medium
Report
Personalis Reports Third Quarter 2025 Financial Results
10/25
11:38 am
psnl
How the Narrative Around Personalis Is Shifting After Recent Analyst Updates and Clinical Progress [Yahoo! Finance]
Medium
Report
How the Narrative Around Personalis Is Shifting After Recent Analyst Updates and Clinical Progress [Yahoo! Finance]
10/22
08:34 am
psnl
Personalis (NASDAQ:PSNL) had its price target raised by analysts at BTIG Research from $6.00 to $11.00. They now have a "buy" rating on the stock.
Medium
Report
Personalis (NASDAQ:PSNL) had its price target raised by analysts at BTIG Research from $6.00 to $11.00. They now have a "buy" rating on the stock.
10/21
04:01 pm
psnl
Personalis to Announce Third Quarter 2025 Financial Results
Medium
Report
Personalis to Announce Third Quarter 2025 Financial Results
10/16
09:00 am
psnl
Personalis Announces New Data from a Landmark Lung Cancer Trial Utilizing Ultrasensitive MRD Testing
High
Report
Personalis Announces New Data from a Landmark Lung Cancer Trial Utilizing Ultrasensitive MRD Testing
9/20
01:09 am
psnl
Low
Report
9/15
05:35 pm
psnl
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)